Vcanbio Cell & Gene Engineering Corp.600645 
$2.59-2.29%24h
-2.29%24h
Global rank7006
Market cap$1.21B
Change 7d-
YTD Performance-9.35%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Vcanbio Cell & Gene Engineering Corp. (600645) Stock Price History
As for today 600645 price is $2.59, a decrease of -2.29% from yesterday.
The highest price of Vcanbio Cell & Gene Engineering Corp. is $11.24 on 2015-09-01. It's also known as the all time high (ATH) which refers to the highest price ever reached by a stock in its trading history.
The lowest price of Vcanbio Cell & Gene Engineering Corp. is $0.17 on 2005-07-01. It's also known as the all time low (ATL) which refers to the lowest price ever reached by a stock in its trading history.
Stock Price History of Vcanbio Cell & Gene Engineering Corp. from to 2024.
-
Value:-
Stock price history for Vcanbio Cell & Gene Engineering Corp. by end of year
| Year | Price | Change |
|---|---|---|
| 2024 | $2.23 | -22.20% |
| 2023 | $2.86 | 19.17% |
| 2022 | $2.40 | -32.61% |
| 2021 | $3.56 | 28.71% |
| 2020 | $2.77 | 15.83% |
| 2019 | $2.39 | 4.25% |
| 2018 | $2.29 | -42.82% |
| 2017 | $4.01 | 5.97% |
| 2016 | $3.78 | -58.78% |
| 2015 | $9.18 | 60.48% |
| 2014 | $5.72 | 69.07% |
| 2013 | $3.38 | 33.56% |
| 2012 | $2.53 | -21.28% |
| 2011 | $3.22 | 142.96% |
| 2010 | $1.32 | 24.57% |
| 2009 | $1.06 | 93.08% |
| 2008 | $0.550793000692022 | -50.57% |
| 2007 | $1.11 | 206.63% |
| 2006 | $0.3634047481181239 | 49.66% |
| 2005 | $0.2428248619486774 | -25.13% |
| 2004 | $0.3243196294151708 | -70.25% |
| 2003 | $1.09 | -19.77% |
| 2002 | $1.36 | 11.61% |
| 2001 | $1.22 | 5.28% |
| 2000 | $1.16 | 98.66% |
| 1999 | $0.5821133503749629 | 13.59% |
| 1998 | $0.5124676938720748 | 16.55% |
| 1997 | $0.4397037016114226 | 36.11% |
| 1996 | $0.3230400949058709 | -4.00% |
| 1995 | $0.3365006284689367 | -39.56% |
| 1994 | $0.5567260299122968 | 57.64% |
| 1993 | $0.3531585860155069 | - |
Price of Vcanbio Cell & Gene Engineering Corp. compared to S&P500 (SPY/US500)
Vcanbio Cell & Gene Engineering Corp. currently underperform the market.
View the most expensive stocks in the world.
